SLC23A2 and cancer: This cancer stem-like cell (CSC) phenotype was associated with an increased expression of sodium vitamin C transporter 2 (SVCT2) as major ascorbate transporter and thereby increased intracellular ROS and ATP depletion upon ascorbate treatment.